InvestorsHub Logo
Followers 58
Posts 7686
Boards Moderated 2
Alias Born 07/07/2002

Re: None

Friday, 03/30/2012 1:10:20 PM

Friday, March 30, 2012 1:10:20 PM

Post# of 4493
From Briefing.com: Threshold Pharma coming under pressure in recent trade; pullback attributed to abstract detail on phase II study of TH-302 combined with gemcitabine (8.07 -0.33) The concern seems to be around the statement that "One death (suicide) was considered possibly related to study drug."


Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MTEM News